Organization
Butantan Institute
12 clinical trials
Clinical trial
Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto ButantanStatus: Active (not recruiting), Estimated PCD: 2021-07-13
Clinical trial
Phase II/III Double-blind, Randomized Clinical Trial With Active Vaccine Control to Evaluate the Safety, Immunogenicity, and Consistency of the Lots of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine in Adults in BrazilStatus: Active (not recruiting), Estimated PCD: 2023-10-05
Clinical trial
Safety and Immunogenicity of the Butantan Institute Trivalent Seasonal Influenza Vaccine in Comparison With the Sanofi Pasteur Trivalent Seasonal Influenza Vaccine in Brazilian Subjects.Status: Completed, Estimated PCD: 2020-01-15
Clinical trial
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate Efficacy and Safety in Healthcare Professionals of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by SinovacStatus: Completed, Estimated PCD: 2020-12-17
Clinical trial
A Stepped-wedge Cluster Randomized Trial to Assess the Effectiveness of the Use of the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by SinovacStatus: Completed, Estimated PCD: 2023-03-07
Clinical trial
Double-blind, Randomized Clinical Trial With Active Controls to Assess Safety, Immunogenicity and Lot-to-lot Consistency of Inactivated Split-virion Quadrivalent Influenza Vaccine of Butantan InstituteStatus: Active (not recruiting), Estimated PCD: 2023-07-08
Clinical trial
A Blind Randomized Clinical Trial, With Active Controls, to Evaluate the Immunogenicity and Safety of the Quadrivalent Influenza Vaccine (Split Virion, Inactivated) From Instituto Butantan, in Infants and Children Aged 6 to 35 Months.Status: Recruiting, Estimated PCD: 2024-03-15
Clinical trial
A Multicenter, Randomized, Controlled, Double Blinded Pivotal Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Virus Vaccine Candidate (VLA1553) in Adolescents Aged 12 Years to <18 YearsStatus: Completed, Estimated PCD: 2023-02-13
Clinical trial
A Phase 2, Randomized, Double-Blind, Multicenter, Safety and Immunogenicity Clinical Bridging Study to Compare V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan-DV) in Healthy Adults 18 to 50 Years of Age in BrazilStatus: Active (not recruiting), Estimated PCD: 2024-01-22
Clinical trial
Double-blind, Randomized, With an Active Control Vaccine, Phase I Clinical Trial for Evaluation of Safety and Immunogenicity of a Recombinant Inactivated COVID-19 Vaccine in Adults in Brazil - ADAPTCOVStatus: Completed, Estimated PCD: 2021-12-10
Clinical trial
Active Pharmacovigilance Study of Post-vaccine Adverse Events of Sinovac's/ Butantan Institute Adsorbed COVID-19 (Inactivated) VaccineStatus: Completed, Estimated PCD: 2023-03-12
Clinical trial
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza the in São Paulo, 2009Status: Completed, Estimated PCD: 2009-06-01